Farah Zia

The National Cancer Institute’s Conference on Acupuncture for Symptom Management in Oncology: State of the Science, Evidence, and Research Gaps

Farah Zia, Oluwadamilola Olaku, Ting Bao et al. · JNCI Monographs · 2017 · 142 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth.

Terry W. Moody, Farah Zia, Muriel Draoui et al. · Proceedings of the National Academy of Sciences · 1993 · 131 citations

Medicine, Oncology, Pharmacology +13

Pituitary adenylate cyclase activating peptide receptors regulate the growth of non-small cell lung cancer cells.

Farah Zia, Mirela O. Fágárásan, Kenan Bitar et al. · PubMed · 1995 · 66 citations · Full text

Medicine, Molecular Biology, Pharmacology +15

Prostaglandin E2 and vasoactive intestinal peptide increase vascular endothelial cell growth factor mRNAs in lung cancer cells

Marchessini Casibang, Sally Purdom, Sonia B. Jakowlew et al. · Lung Cancer · 2001 · 57 citations

Life Sciences, Molecular Biology, Oncology +13

Neuromedin B binds with high affinity, elevates cytosolic calcium and stimulates the growth of small-cell lung cancer cell lines.

Terry W. Moody, Julie K. Staley, Farah Zia et al. · Journal of Pharmacology and Experimental Therapeutics · 1992 · 55 citations

Medicine, Oncology, Pharmacology +16